These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 25466295)

  • 1. The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy.
    Roeleveld DM; Koenders MI
    Cytokine; 2015 Jul; 74(1):101-7. PubMed ID: 25466295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
    Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
    BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis.
    Paulissen SM; van Hamburg JP; Dankers W; Lubberts E
    Cytokine; 2015 Jul; 74(1):43-53. PubMed ID: 25828206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.
    Azizi G; Jadidi-Niaragh F; Mirshafiey A
    Int J Rheum Dis; 2013 Jun; 16(3):243-53. PubMed ID: 23981743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation.
    Ye L; Jiang B; Deng J; Du J; Xiong W; Guan Y; Wen Z; Huang K; Huang Z
    J Immunol; 2015 Jun; 194(11):5110-9. PubMed ID: 25917106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IL-17 and IL-22 in autoimmunity and cancer.
    Blake SJ; Teng MW
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17/Th17 mediated synovial inflammation is IL-22 independent.
    van Hamburg JP; Corneth OB; Paulissen SM; Davelaar N; Asmawidjaja PS; Mus AM; Lubberts E
    Ann Rheum Dis; 2013 Oct; 72(10):1700-7. PubMed ID: 23328939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?
    Lubberts E
    Cytokine; 2008 Feb; 41(2):84-91. PubMed ID: 18039580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-15 induces interleukin-17 production by synovial T cell lines from patients with rheumatoid arthritis.
    Halvorsen EH; Strønen E; Hammer HB; Goll GL; Sollid LM; Molberg O
    Scand J Immunol; 2011 Mar; 73(3):243-9. PubMed ID: 21204897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis.
    van Hamburg JP; Tas SW
    J Autoimmun; 2018 Feb; 87():69-81. PubMed ID: 29254845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis.
    Benedetti G; Miossec P
    Eur J Immunol; 2014 Feb; 44(2):339-47. PubMed ID: 24310226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated circulating Th17 and follicular helper CD4(+) T cells in patients with rheumatoid arthritis.
    Zhang Y; Li Y; Lv TT; Yin ZJ; Wang XB
    APMIS; 2015 Aug; 123(8):659-66. PubMed ID: 25912557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy.
    Xu WD; Zhang M; Zhang YJ; Ye DQ
    Hum Immunol; 2013 Sep; 74(9):1057-60. PubMed ID: 23800433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes.
    Hot A; Miossec P
    Ann Rheum Dis; 2011 May; 70(5):727-32. PubMed ID: 21345813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifaceted role of IL-21 in rheumatoid arthritis: Current understanding and future perspectives.
    Dinesh P; Rasool M
    J Cell Physiol; 2018 May; 233(5):3918-3928. PubMed ID: 28833093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis: implication to clinical therapeutics.
    Dong W; Zhu P
    Autoimmun Rev; 2012 Oct; 11(12):844-51. PubMed ID: 22406293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
    Yamagata T; Skepner J; Yang J
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis.
    Miao J; Zhang K; Lv M; Li Q; Zheng Z; Han Q; Guo N; Fan C; Zhu P
    Scand J Rheumatol; 2014; 43(3):194-201. PubMed ID: 24392804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IL-12/IL-23 axis and its role in Th17 cell development, pathology and plasticity in arthritis.
    Cornelissen F; van Hamburg JP; Lubberts E
    Curr Opin Investig Drugs; 2009 May; 10(5):452-62. PubMed ID: 19431078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.